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Abstract It is known that cellular signals produced in response
to an inappropriate spindle formation cause the cell to be
arrested at metaphase (M) in the cell cycle. We report here that
the 42-kDa isoform of MAPK (ERK2) was tyrosyl-phosphory-
lated and activated in response to epidermal growth factor (EGF)
in interphase but not in M-arrested HeLa cells. However, the
basal level of activity of M-arrested cells was higher than that of
interphase, although the overall tyrosyl phosphorylation content
was small. Further, the EGF receptor and its associated proteins
GTPase-activating protein and phospholipase C were phosphory-
lated in M-arrested cells to a lower extent than they were in
interphase. This implies that in spite of its high level of basal
activity, the scarcity of MAPK activation in mitosis in response
to EGF stems from an early impairment of phosphorylation of
the receptor and neighboring proteins. The biological significance
of these results underlies the importance of keeping the cell
sheltered from extracellular signals when it undergoes division.
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1. Introduction
Binding of epidermal growth factor (EGF) to its receptor
induces a rapid receptor dimerization resulting in cross-phos-
phorylation of the subunits on tyrosine residues and a con-
comitant activation of the tyrosine kinase enzymatic activity
within the intracellular domain. The multi-phosphorylated re-
gion provides speci¢c binding sites for cytosolic enzymes con-
taining SH-2 and SH-3 domains (e.g. phospholipase C
(PLCQ1), GTPase-activating protein (GAP)) that form a com-
plex with the receptor and become tyrosyl-phosphorylated
and activated. Activation of Ras, and Raf and MEK kinases,
eventually activates mitogen-activated protein kinases
(MAPKs). The p42mapk isoform is a key player in the signal-
ing mechanisms that transduce mitogenic signals from an ac-
tivated receptor kinase to cell interior molecules including the
ribosomal S6 kinase (R6K) [1,2].
MAPK plays a role in: (a) the G0/G1 transition that is
initiated by EGF and related growth factors in proliferating
cells [3^5]; (b) the reentry into the cell cycle of meiosis-ar-
rested Xenopus oocytes as induced by extracellular signals
[6] ; and (c) response to inappropriate spindle assembly during
mitosis of either proliferating cultured cells [7] or cycling Xen-
opus eggs [8,9]. In fact, activation of MAPK leads to both a
metaphase arrest in oocytes, embryonic or adult cells [10,11]
and a G2 arrest in Xenopus eggs [12]. MAPK is activated by
microinjection of maturation-promoting factor (MPF) to cell-
free extracts of interphase eggs [13]. It has also been demon-
strated that in addition to the spindle assembly checkpoint,
activation of MAPK at inappropriate times prevents normal
entry into M phase [14].
In general, these studies have relied upon the addition of
constitutively active Ras, Mos or MAPK/MEK mutants as
activators of the MAPK signaling pathway. In spite of this
and of the presence of an observable spindle arrest, it has been
di⁄cult to observe an activated MAPK during the M phase of
somatic cell cycles. Additionally, it is not well known whether
an active MAPK, if present during the M phase, will respond
to extracellular signals like those inducing G0 exit or meiosis
resumption. Several observations support the concept that
mitosis is a period in which cells are insulated from environ-
mental regulation: cell adhesion, membrane transport, arach-
idonic acid and Ca2 in£ux are abolished in several cell lines
[15,16]. We report here that MAPK was selectively blocked to
respond to an extracellular stimulus during metaphase, and
that this was due, at least partially, to a lower phosphoryla-
tion of the receptor. Since MAPK plays such a central role in
signal transduction, it can be bene¢cial for the cell to turn o¡
certain functions that might need to remain inactive during
the critical stages of cell division.
2. Materials and methods
2.1. Materials and antibodies
Recombinant human EGF was purchased from Chiron (Emerville,
CA); IgG agarose beads, colcemid (demecolcine) and MBC were from
Sigma (St. Louis, MO); DFP was from Aldrich (Milwaukee, WI);
Immobilon PVDF membranes were from Millipore Corporation
(Bedford, MA); electrophoresis chemicals were from Bio-Rad Labo-
ratories (Richmond, CA); [Q-32P]ATP (30 Ci/mol) was from Amer-
sham Life Sciences (Arlington Heights, IL); anti-p42mapk, anti-
PLCQ1 and anti-GAP antibodies were from Upstate Biotechnology
Inc. (Lake Placid, NY); anti-PY and anti-EGFcR were from Chem-
icon International Inc. (Temecula, CA).
2.2. Cell culture and synchronization
The model used in this study comprised exponentially growing,
cultured human cervical carcinoma HeLa cells: ‘interphase’, and col-
cemid-treated cells that were taken o¡ the cell culture dish ‘mitosis’, as
follows. HeLa-S3 cells were seeded at 1U105 cells/ml on 100 mm
Falcon tissue culture dishes and grown in monolayers in F-12 medium
supplemented with L-glutamine and 7% FBS as described [16]. Mitotic
cells were obtained by continuous exposure of monolayers to 0.1 Wg/
ml colcemid during 15 h. The loosely attached, rounded-up mitotic
cells were collected the following day by gentle shaking of the plates
and concentrated by centrifugation. Fluorescent microscopy of
Hoechst 33258-stained cells showed a v95% mitotic index. In control
experiments, removal of colcemid makes cells capable of again attach-
ing to the cell culture dishes and V80% progress into G1. To create
interphase populations similar to those of M-arrested, normally grow-
ing cells were transferred from the Falcon tissue culture plastic to
Petri dishes on which growth occurs in suspension. Cells remain
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rounded after 24 h culture and are easily collected without the need of
trypsin treatment. The interphase population contained 5^10% mi-
totics at any given time.
2.3. Preparation of cell extracts and immunoprecipitation
This was done as indicated previously in [17] with slight modi¢ca-
tions. Brie£y, at the time of the experiment, cells were incubated at
37‡C and stimulated with 100 nM EGF. Cell suspensions were lysed
with boiling 1% SDS and diluted with 9 volumes of an ice-cold lysis
bu¡er (0.1 M HEPES, pH 7.3, 0.7 mM sodium orthovanadate, 10
mM p-nitrophenyl phosphate (PNPP), 10 mM EGTA, 5.5% Triton
X-100, 0.5 M L-glycerophosphate, 10 mM phenylmethylsulfonyl £uo-
ride (PMSF), 0.1 mM ammonium molybdate, 12 mM DFP, 5 mg/ml
leupeptin, 2 mg/ml aprotinin and 7 mg/ml pepstatin A). Cell lysates
were incubated on ice for 20 min and then centrifuged for 5 min at
7000Ug. Supernatants were incubated overnight with the primary
antibody, at a ¢nal concentration of 1 mg/ml, and with anti-rabbit
(IgG, whole molecule) antibody conjugated to agarose beads (ratio
agarose beads/cell lysates 1:2). Immune complexes were recovered by
centrifugation. Pellets were washed two times with lysis bu¡er, two
times with bu¡er A (0.1 M Tris-HCl, pH 7.4, 0.4 M LiCl) and two
times with bu¡er B (0.01 M Tris-HCl, pH 7.4, 0.1 M NaCl, 1 mM
EDTA). Western blotting was performed as described previously [17].
2.4. MAP kinase enzymatic assay
The enzymatic activity of p42mapk was ¢rst measured in vitro as
initially described [18]. 16 WM MBP was diluted in kinase bu¡er
(13.4 mM HEPES, pH 7.3, 25 mM MgCl2, 30 mM Na2VO3, 5 mM
PNPP, 2 mM EGTA, 2 mM cAMP-dependent kinase inhibitor, 21
mCi [Q-32P]ATP/ml (7 nM), and 68 mM unlabeled ATP). To initiate
the phosphotransferase reaction, aliquots (20 Wl) of kinase bu¡er were
mixed 1:1 (v/v) with the cell lysates. The reaction was carried out at
25‡C for 10 min, and terminated by blotting 20 Wl of the reaction
mixture onto ion-exchange cellulose phosphate ¢lters. After washing,
they were counted for radioactivity. The enzymatic activities of the
mentioned kinases were also measured following the in-gel kinase
assay as described previously [19]. Brie£y, 250 Wg/ml MBP was mixed
with SDS-PAGE gel solution before gel polymerization. After electro-
phoresis, gels were washed free of SDS by incubation with 20% iso-
propanol in bu¡er A (100 mM Tris-HCl, pH 8, 5 mM L-mercapto-
ethanol). Gels were then incubated with bu¡er A containing 6 M
guanidine-HCl and proteins were renatured by incubation at 4‡C
for 6 h in bu¡er A containing 0.04% Tween 40. Renatured gels
were overlaid with kinase bu¡er (20 mM Tris-HCl, pH 8, 10 mM
MgCl2, 25 mCi [Q-32P]ATP) and incubated at room temperature for
30 min. Gels were extensively washed with 1% pyrophosphate in 5%
trichloroacetic acid, dried and exposed to X-ray ¢lms. For immuno-
precipitation experiments cell lysates were obtained as described
above except that the boiling 1% SDS step was omitted. Beads were
resuspended in 30 Wl of lysis bu¡er prior to electrophoresis loading.
3. Results
3.1. MAPK basal activity was increased in M-arrested cells
As indicated in Fig. 1A, an increased (up to 3.7-fold)
MAPK activity was observed in interphase HeLa cells follow-
ing incubation of cells with EGF. In contrast, a minimal acti-
vation was observed in M-arrested HeLa cells under similar
conditions. Interestingly, the level of basal activity of these M-
arrested cells was consistently higher than that of interphase
cells in the absence of any stimulus. To explore these obser-
vations further, we ¢rst performed an immunoprecipitation
with anti-p42mapk antibodies, to unequivocally con¢rm the
kinase activity that been analyzed was that of the 42-kDa
isoform of MAPK, and second a renatured in-gel kinase assay
against the substrate embedded in the gel matrix. These ex-
periments yielded con¢rmatory results (Fig. 1B): (i) an in-
crease in phosphotransferase activity elicited by EGF most
prominently in interphase cells, and (ii) an overall high basal
activity level in mitosis.
3.2. MAPK was strongly tyrosyl phosphorylated in response to
EGF in interphase cells
Since an increase in enzymatic activity might be the result
of a covalent modi¢cation (i.e. phosphorylation) on the
MAPK molecule, we checked for mobility shifts in SDS gels
before and after EFG stimulation of HeLa cells. Interphase
HeLa cells treated with EGF underwent mobility shifts in
p42mapk shortly after stimulation (Fig. 2A). Note an upper
band (*p42) present in the interphase stimulated cells that is
absent in the mitotic counterpart, and a lower band (p42)
present in mitotic cells at all times, and in interphase cells
present only in resting conditions. Conversely, M-arrested
cells failed to show any mobility shift, in agreement with the
enzymatic assay data. The mitotic population failed to show
any signi¢cant change even at the highest dose of ligand used
(100 nM).
Immunoprecipitation of MAPK further demonstrated that
a tyrosyl phosphorylated form of MAPK was elevated with
EGF (Fig. 2B). Quanti¢cation of the *p42 band (ODUArea)
expressed as a PY/MAPK ratio was: [Interphase]3EGF = 1.8/
0.50 = 3.6 [Interphase]EGF = 5.7/0.36 = 15.8, resulting in an ac-
tivation by EGF of 4.4-fold. Conversely, no changes on ty-
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Fig. 1. Enzymatic analysis of MAPK in HeLa cells. A: In vitro kin-
ase enzymatic activity analysis. Interphase and M-arrested HeLa
cells (1U107 cells/ml) were treated with 100 nM EGF for 0, 3 or 5
min, and lysates (1.6 mg/ml protein) were obtained as indicated
above. These were subjected to an in vitro kinase assay against
MBP in the presence of [Q-32P]ATP using the same total protein
concentration (20 Wg in 40 Wl, ¢nal reaction volume, for each condi-
tion). Solid bars: controls; hatched bars: EGF-stimulated cells. The
¢gure represents the mean þ S.E.M. of four experiments. B: Anti-
p42mapk immunoprecipitates were electrophoresed in SDS polyacryl-
amide gels polymerized in the presence of 250 Wg/ml MBP. After
electrophoresis gels were subjected to the ‘in-gel’ kinase reaction in-
volving protein renaturation and overlaying with [Q-32P]ATP as ex-
plained in Section 2. Shown are regions of the gels between 33 and
48 kDa, representative of three other experiments performed sepa-
rately.
J. Gomez-Cambronero/FEBS Letters 443 (1999) 126^130 127
rosyl phosphorylation were detected on the mitotic counter-
part even though enough MAPK had been brought down by
the antibody (Fig. 2C). Interestingly, little phosphotyrosine
could be detected in M-arrested cells. Since mitotic cells
were prepared by exposing unsynchronized cells to colcemid
for 16 h, interphase controls were run with cells treated with
the drug for only 1 h. The phosphorylation pattern of these
cells is virtually identical to that derived from freshly har-
vested interphase cells (not shown) suggesting that the ob-
served e¡ects are not due to colcemid per se, but rather result
from the cell cycle phase.
3.3. The EGFcR and associated proteins were activated in
M-arrested cells to a lower extent
Exploring the di¡erences in responsiveness towards EGF of
the interphase and mitosis cells, we found that the lack of an
increase on tyrosyl phosphorylation in M-arrested cells was
not speci¢c for p42mapk, since other proteins were tyrosine
phosphorylated to a lower extent in mitosis (Fig. 3A). Exam-
ple of these were p183, p158 and p122. Since MAPK tyrosine
phosphorylation did not take place in mitotic cells stimulated
with EGF, we tested whether the EGF-induced signaling
pathways were interrupted at the point of the receptor. As
indicated in Fig. 3B, starting from equal protein concentra-
tions on both subpopulations the anti-EGFcR antibody was
able to immunoprecipitate the receptor (p183 protein) that
was in the tyrosyl phosphorylated form in samples derived
from EGF-treated cells. It could be observed that the phos-
phorylated receptor was 20^30% decreased in mitotic phase
with respect to interphase. Similar results were obtained with
SH-2 and SH-3 domain-rich proteins that associate with the
EGF receptor, particularly PLCQ1 (Fig. 3C,D) and GAP (not
shown). From dose-response experiments performed stimulat-
ing HeLa cells with 0.1^100 nM EGF, analysis of phosphory-
lated proteins and quantitative densitometric scans (ODUAr-
ea) of the EGFcR the results presented in Fig. 4A were
obtained. It could be observed that although the apparent
a⁄nity of receptor activation was comparable in interphase
and mitotic cells (V1 nM), saturation on mitosis never
reached the levels of interphase. For comparison, Fig. 4B
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Fig. 3. A: Tyrosyl phosphorylation pattern of HeLa total cell ex-
tracts. Interphase or mitotic subpopulations were treated with or
without EGF for 1 or 3 min. Lysates were subjected to Western
blotting developed with anti-PY antibodies. The ticks on the left
mark the position of relevant proteins as discussed in the text:
p183: EGFcR; p158: PLCQ1; and p122: GAP. The asterisks on the
right show the molecular weights (in kDa) of the protein markers
run with the SDS gels. B^D: Signaling molecules upstream of
MAPK. Lysates from interphase or mitotic subpopulations un-
treated or stimulated with EGF were immunoprecipitated with anti-
EGFcR (B) or anti-PLCQ1 (C,D) and probed with anti-PY (B,C) or
anti-PLCQ1 (D). Shown are results from a typical experiment among
four.
Fig. 2. Detection of p42 MAPK. A: In HeLa total cell lysates.
HeLa interphase or mitotic cells (1U107 cells/ml) were incubated
with or without 100 nM EGF for 5 min. The resulting blots were
probed with anti-PY antibodies. Shown is a region of the blot that
spans from 36 to 52 kDa. B: HeLa anti-p42mapk immunoprecipi-
tates. MAPK was immunoprecipitated with anti-p42mapk antibody
on SDS-boiled lysates (1.6 mg/ml protein) from interphase and mi-
totic HeLa cells unstimulated (3) or treated with 100 nM EGF (+).
Western blots of immunocomplex beads were probed with anti-PY
antibodies. C: HeLa anti-p42mapk immunoprecipitates and Western
blots probed with anti-p42mapk antibodies. *p42 marks the position
of the phospho form of p42-MAPK, while p42 marks the position
of the dephospho form. Shown are representative experiments among
¢ve.
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shows the scanning of the p42mapk. Fig. 4C^E presents the
phosphotyrosyl content of EGFcR, PLCQ1 and GAP. Thus,
the small MAPK tyrosyl phosphorylation in mitosis in re-
sponse to EGF seemed to stem from an early impairment of
phosphorylation of the receptor and associated proteins.
4. Discussion
We provide evidence that (i) p42mapk becomes fully acti-
vated in response to EGF treatment in normally cycling (in-
terphase) cells, but they fail to do so when cells are arrested in
metaphase with colcemid treatment, and (ii) a higher level of
basal activity exists in M-arrested cells as compared with the
interphase counterpart. For the ¢rst ¢nding, the fact that cells
do not respond to EGF in mitosis, it could be advantageous
to the mitotic cell. In the event of an external stimulation, the
cell has the possibility of using all the kinases which have been
activated upon entering mitosis. However, our results suggest
that the mitotic cell does not take advantage of the mecha-
nisms that have been described for other phases of the cell
cycle (e.g. G0/G1 reentry that can account for part of the
observed e¡ects in interphase) upon external stimulation. Giv-
en that MAP kinase is a crucial signal transduction link, turn-
ing it on at inappropriate times could lead to a number of
unwanted responses, such as the phosphorylation of MAPs
that are already involved in the formation of the spindle. In
this respect, MAP kinase that was exogenously added to Xen-
opus oocyte extracts in interphase induced a change to M
phase of microtubule dynamics [20]. Microtubule protein
p220 is a natural target for both MAP kinase and MPF
also in Xenopus oocytes. Therefore, the mitotic cell suppresses
con£icting signals while it is engaged in mitotic spindle for-
mation, chromosome separation and all the events associated
with this phase of the cell cycle.
As for the increase in MAPK activity in mitosis, it is known
that during mitosis an elevated turnover of protein covalent
modi¢cation (both Ser/Thr and Tyr phosphorylation) takes
place. Only in the G2/M transition, the regulatory light chain
of myosin II, nuclear laminins, vimentin, and histones 1 and
3, are heavily phosphorylated. Our result of high MAPK en-
zymatic activity in cycling mammalian cells is in agreement
with previous work in meiotic cell cycles of Xenopus oocytes
[13,21] and with the activities of p38 MAPK and MPF in M-
arrested ¢broblasts [22]. Although it is clear that an exoge-
nously activated MAPK causes profound changes during mi-
tosis, it has been di⁄cult to consistently show that MAPK is
active in M-arrested cells. Edelmann et al. [23] have demon-
strated that p42mapk/p44mapk are already phosphorylated dur-
ing anaphase of mitosis, thus making these two proteins active
at the end of mitosis and through the very early part of G1
after nocodazole release of 3T3 ¢broblasts. We cannot exclude
the possibility that in our studies some cells have progressed
from metaphase to anaphase in the period from mechanical
shake o¡ of rounded mitotic cells, centrifugation, resuspen-
sion in fresh bu¡er and lysate preparation. Tamemoto et al.
[24] have demonstrated that both p42 and p44 MAPKs are
activated biphasically, in the G1 phase and around the M
phase in Chinese hamster ovary cells. Interestingly, there is
little activity in nocodazole-arrested cells, but an elevated level
of activity is found in the subsequent cell cycle after arrest
release. Heider et al. [25] have reported a strong kinase activ-
ity, particularly in nocodazole-arrested HeLa cells, that slowly
declines after drug removal. However, a failure of immuno-
precipitate MBP kinase activity with anti-ERK2 antibodies
led these authors to postulate the existence of a 40-kDa kinase
as a novel mitotic kinase. In the report by Takenaka et al.
[22], it is possible to observe that MAPK is activated in ¢bro-
blasts although at a lower rate than p38, and its study was not
pursued any further. Often, results vary between arrested cells
(by a spindle-disrupting drug) and their release into a subse-
quent cell cycle.
The surprising ¢nding that activated MAPK in mitosis is
not accompanied by tyrosyl phosphorylation can be explained
in terms of a hyperphosphorylation of MAPK in Ser/Thr in
this particular phase of the cycle and thus it could not be
detected by the anti-PY antibodies. Indications that this might
be the case are given by two recent reports (that also under-
line the importance of MAPK in somatic cell mitosis) in
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Fig. 4. Dose-response curve of the tyrosyl phosphorylated EGFcR and EGFcR. Interphase (a) or M-arrested (b) HeLa cells were incubated
with the indicated concentrations of EGF (in nmol/ml) for 5 min and blots were generated. The p183/EGFcR (A) or the 42-kDa/MAPK (B)
band in X-ray ¢lms was analyzed by quantitative densitometric scanning at 633 nm. The optical density (OD) was linear with the range consid-
ered. In the ordinate axis, the [ODUArea] of the band is presented. The ¢gure represents the mean þ S.E.M. of four experiments. C^E: Blots
developed with anti-PY of p183/EGFcR (from which scanning presented in A was obtained); p158/PLCQ1 and p122/GAP, respectively.
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which: (i) dephosphorylation by dual-speci¢c phosphatase
XCL100 of Erk2 renders Xenopus tadpole cells unable to re-
main arrested in mitosis after treatment with nocodazole [26]
and (ii) dephosphorylation of phosphorylated Bcl-2 by the
Ser/Thr kinase inhibitor staurosporine, but not the Tyr kin-
ases inhibitor genistein, led to progression of M-arrested
HeLa into interphase [27].
Going back to the observation of a lack of MAPK activa-
tion in response of mitotic cells to EGF, the most likely ex-
planation could be found in terms of a failure of the mitotic
EGF receptor to function normally in this phase of the cycle.
Our data demonstrated that the EGFcR as well as two asso-
ciated proteins, PLCQ1 and GAP, were tyrosyl phosphory-
lated to a lower extent in mitosis than they were in interphase.
This is in agreement with [28]. Similarly, EGFcR tyrosine
phosphorylation was not observed in rat-1 cells but it was
in A331, MDAMB-468 and Her-5, cells that naturally or ar-
ti¢cially overexpress the receptor [29]. Cells express the same
number of receptors in any phase of the cycle. However, re-
sults are di¡erent in A431 and rat-1 cell lines, where binding is
the same in G0/G1 and M in the former and di¡erent in the
latter. Others have also found di¡erences depending upon the
method of synchronization. While EGF-induced activation of
phospholipid hydrolysis did not operate properly in mitotic
HeLa cells [30], phosphorylation of EGFcR and PLCQ1 is seen
in mitosis after amethopterin inhibition and thymidine release,
while little or no phosphorylation is seen in mitosis of noco-
dazole-arrested cells.
In the absence of a general consensus, it seems that a block-
age such as that reported here, leading to compromised
MAPK activation in response to EGF in mitosis, is initiated
at the receptor level, but other components might still lie
downstream of it, presumably the presence of an intricate
system of proteases [31] and phosphatases that e⁄ciently
maintain the equilibrium of phosphorylated proteins [32].
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